News Focus
News Focus
Post# of 257273
Next 10
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

Re: DewDiligence post# 121459

Saturday, 06/11/2011 8:04:10 PM

Saturday, June 11, 2011 8:04:10 PM

Post# of 257273
>You’re going around in circles. As noted in #msg-64138359, the advisory committee rejected laViv on safety, and there are always going to lingering worries about safety when a biologically active cell-based product is used for a cosmetic indication.<

From the:
FDA Cellular, Tissue and Gene Therapies Advisory Committee
Summary Minutes
Meeting #48, October 9, 2009:

> There was general consensus among the Committee that as the product is derived from autologous cells, the risk of tumorgenicity from these cells is low. However, the committee was concerned that insufficient data had been presented on the characterization of the implanted cells to adequately assess the safety of the product. The Committee stated that more information is needed on; the survival and fate of the implanted cells; collagen production by implanted cells; the effect of passage number on the potential for tumorigenicity; the effect of growth-factors and other proteins secreted by implanted cells on the potential for tumorgenicity; and the effect of cell-mediated immune responses.
The Committee discussed the need for a greater than 12-month safety follow-up period for patients, including possible follow-up biopsies of implanted site(s). The Committee also briefly discussed other risk factors such as age (greater than 65); genetic predisposition to cancer; heavy smoking.<

http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM214839.pdf

This is directly from the advisory committee minutes.
They voted 6-8 against 19 months ago (close but no cigar).
The committee wanted a greater than 12-month safety follow-up period to see if implanted cells remained productive and there were any other significant safety issues.
19 months have passed and there have not been any significant safety issues.

I am strictly interested in their odds of approval.
I think it's better than a 60% bet they get a vote in favor of approval.
Better than the lottery but I'd rather play blackjack.



Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today